Machine Learning

Crypto exchange Coinlocally adds tokenized shares of Tesla and Apple, using a zero-fee campaign to attract traders to the burgeoning RWA market.

A new drug for a life-threatening genetic heart condition begins late-stage trials, earning FDA Fast Track to potentially speed its path to patients.

HCL Group and the WEF's UpLink are seeking innovators to solve the global water crisis with a new challenge aimed at transforming our future water systems.

A new startup claims its V2700 router can cover a 15,000 sq ft home, killing dead zones without mesh. But can its new RPU tech deliver on the hype?

With a seasoned dealmaker at the helm, Elkedonia is advancing a first-in-class, non-hallucinogenic drug for depression targeting a novel protein.

The new decentralized platform Delphi uses verifiable AI to let creators monetize their insights, challenging the multi-billion dollar prediction market industry.

As prop firms boom, a major deal shows how institutional-grade surveillance is becoming critical to manage risk and legitimize a new generation of traders.

CAAS posts record sales and EPS for 2025, fueled by a strategic shift to advanced electric steering systems and aggressive international expansion.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

A new imaging tool eliminates background noise, offering a revolutionary, high-definition view into the cellular processes that drive life and disease.

The education giant posted a 45% profit jump driven by new business lines and e-commerce, signaling its strategic transformation is a resounding success.

Parade Technologies posts lower Q1 profits despite a flurry of industry-first chip launches for AI data centers, automotive, and next-gen notebooks.

A new powerhouse residency program backed by Silicon Valley elite launches near Stanford to turn academic science into fundable healthcare companies.

Winning Adobe's top partner award for a third straight year, Adswerve combines strategic talent acquisition with deep technical mastery to redefine market leadership.

The diabetes tech firm posted a 57% revenue jump and lifted its 2026 outlook, but a sequential drop in new users raises questions for investors.

Garnering top awards for value and support, STRATAFOLIO's success highlights a move towards user-validated efficiency and a new AI-driven future for CRE.

Remix Therapeutics' first-in-class drug REM-422 targets a rare cancer at its genetic source, with pivotal data set for a major oncology conference.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

A new, university-validated diagnostic offers free, data-backed insights into team effectiveness, challenging the HR tech market's focus on individuals.

Akima's Pinnacle Solutions will deliver virtual reality training systems for the USMC's ACV fleet, aiming to boost technician skill and operational readiness.